Illumina Inc. (ILU.DE)
140.10
-0.62 (-0.44%)
At close: Jan 14, 2025, 4:39 PM
undefined% (undefined)
| Bid | n/a |
| Market Cap | 22.22B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -9.69 |
| PE Ratio (ttm) | -14.46 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 463 |
| Avg. Volume (20D) | 165 |
| Open | 142.22 |
| Previous Close | 140.72 |
| Day's Range | 137.46 - 143.30 |
| 52-Week Range | 93.00 - 150.56 |
| Beta | undefined |
About ILU.DE
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequenci...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Oct 15, 2007
Employees 10,590
Stock Exchange XETRA
Ticker Symbol ILU.DE
Website https://www.illumina.com